The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.

Autor:	Yang CJ; Duke University Medical Center, Durham, NC., Yendamuri S; Roswell Park Cancer Institute, Buffalo, NY., Mayne NR; Duke University Medical Center, Durham, NC., Battoo A; Roswell Park Cancer Institute, Buffalo, NY., Wang H; Duke University Medical Center, Durham, NC., Meyerhoff RR; Duke University Medical Center, Durham, NC., Vandusen K; Duke University Medical Center, Durham, NC., Hirji SA; Brigham and Women's Hospital, Boston, Mass., Berry MF; Stanford University, Stanford, Calif., McKenna RJ Jr; St John's Health Center, Santa Monica, NC., Demmy TL; Roswell Park Cancer Institute, Buffalo, NY., D'Amico TA; Duke University Medical Center, Durham, NC. Electronic address: Thomas.damico@duke.edu.
Jazyk:	angličtina
Zdroj:	The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2019 Jul; Vol. 158 (1), pp. 252-264.e2. Date of Electronic Publication: 2018 Dec 18.
DOI:	10.1016/j.jtcvs.2018.12.001
Abstrakt:	Objective: The objective of this study was to evaluate the impact of the video-assisted thoracoscopic (VATS) approach on the outcomes of patients who underwent pneumonectomy. Methods: The effect of the surgical approach on perioperative complications and survival in patients who underwent pneumonectomy for nonmetastatic non-small cell lung cancer across 3 institutions (2000-2016) was assessed using multivariable logistic regression, Cox proportional hazards analysis, and propensity-score matching. Completion pneumonectomies were excluded from this study, and an "intent-to-treat" analysis was performed. Results: During the study period, 359 patients met inclusion criteria and underwent pneumonectomy for nonmetastatic non-small cell lung cancer; 124 (35%) underwent pneumonectomy via VATS and 235 (65%) via thoracotomy. Perioperative mortality (VATS, 7% [n = 9] vs open, 8% [n = 19]; P = .75) and morbidity (VATS, 28% [n = 35] vs open, 28% [n = 65]; P = .91) were similar between the groups, even after multivariable adjustment. VATS showed similar 5-year survival when compared with thoracotomy in unadjusted analysis (47% [95% confidence interval (CI), 36-56] vs 33% [95% CI, 27-40]; P = .19), even after multivariable adjustment (hazard ratio, 0.76 [95% CI, 0.50-1.18]; P = .23). In a propensity score-matched analysis that balanced patient characteristics, there were no significant differences found in overall survival between the 2 groups (P = .69). Conclusions: Although the role of VATS pneumonectomy will likely become clearer as more surgeons report results, this multicenter study suggests that the VATS approach for pneumonectomy can be performed safely, with at least equivalent oncologic outcomes when compared with thoracotomy. (Copyright © 2018. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu